Cigna Corporation (CI): Price and Financial Metrics
Cigna Corporation (CI)
Today's Latest Price: $226.19 USD
Updated Jan 21 4:00pm
Add CI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 8 in Medical - Health Insurance
See all "A" rated Strong Buy stocks
CI Stock Summary
- CI has a higher market value than 97.3% of US stocks; more precisely, its current market capitalization is $82,520,672,098.
- CI's went public 35.08 years ago, making it older than 92.82% of listed US stocks we're tracking.
- CI's price/sales ratio is 0.53; that's higher than the P/S ratio of only 13.11% of US stocks.
- Stocks that are quantitatively similar to CI, based on their financial statements, market capitalization, and price volatility, are MDLZ, ANTM, BKNG, INFY, and TJX.
- CI's SEC filings can be seen here. And to visit Cigna Corp's official web site, go to www.cigna.com.
CI Stock Price Chart Interactive Chart >
CI Price/Volume Stats
| Current price | $226.19 | 52-week high | $230.90 |
| Prev. close | $228.42 | 52-week low | $118.50 |
| Day low | $226.08 | Volume | 2,074,874 |
| Day high | $230.90 | Avg. volume | 2,016,892 |
| 50-day MA | $211.63 | Dividend yield | 0.02% |
| 200-day MA | $189.67 | Market Cap | 81.71B |
Cigna Corporation (CI) Company Bio
Cigna Corporation offers medical, dental, disability, life and accident insurance and related products and services. The Company operates in three segments: Global Health-Care, Global Supplemental Benefits and Group Disability and Life. The company was founded in 1792 and is based in Bloomfield, Connecticut.
CI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $226.19 | $746.93 | 227% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Cigna Corp. To summarize, we found that Cigna Corp ranked in the 75th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 228.67%. The most interesting components of our discounted cash flow analysis for Cigna Corp ended up being:
- The company's balance sheet shows it gets 70% of its capital from equity, and 30% of its capital from debt. Notably, its equity weight is greater than merely 20.97% of US equities in the Healthcare sector yielding a positive free cash flow.
- Cigna Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than just 7.62% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 221% |
| 1% | 224% |
| 2% | 227% |
| 3% | 230% |
| 4% | 233% |
| 5% | 237% |
LHCG, VTRS, SUPN, UHS, and ARA can be thought of as valuation peers to CI, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...